MedTrace Logo

Safety and Efficacy of the Ultimaster Stent

NCT05677711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2025-11-25

No results posted yet for this study

Summary

Durable polymer was considered to be the cause of a chronic inflammatory response that leadas to impaired endothelialization of the stent strut and subsequently increases the risk of stent thrombosis. Ultimaster stent (Ultimaster, Terumo Corporation, Tokyo, Japan) are thin strut, silorimus-eluting, biodegradable copolymer to completely degrade over 3-4 months.

Conditions

Interventions

DEVICE

ultimaster

Subjects who received Ultimaster stent will be included.

Sponsors & Collaborators

  • Terumo Corporation

    collaborator INDUSTRY

  • Yonsei University

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-20
Primary Completion
2024-09-24
Completion
2025-01-03

Countries

  • South Korea

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05677711 on ClinicalTrials.gov